Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

NovaBridge Biosciences (NBP) Shareholder's Equity (2017 - 2025)

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2025	230.94 Mn
Sep 30, 2025	258.92 Mn
Jun 30, 2025	196.73 Mn
Mar 31, 2025	198.34 Mn
Dec 31, 2024	201.16 Mn
Sep 30, 2024	217.88 Mn
Jun 30, 2024	236.63 Mn
Dec 31, 2023	238.63 Mn
Jun 30, 2023	337.43 Mn
Dec 31, 2022	409.14 Mn
Jun 30, 2022	599.59 Mn
Dec 31, 2021	713.16 Mn
Jun 30, 2021	845.60 Mn
Dec 31, 2020	849.10 Mn
Sep 30, 2020	551.08 Mn
Dec 31, 2019	-288.68 Mn
Dec 31, 2018	-138.14 Mn
Dec 31, 2017	-45.31 Mn